| Dr James A Boyd Jr, MD | |
|
7200 Wyoming Spgs, Ste 600, Round Rock, TX 78681-4305 | |
| (512) 244-1995 | |
| (512) 244-2090 |
| Full Name | Dr James A Boyd Jr |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 36 Years |
| Location | 7200 Wyoming Spgs, Round Rock, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629073929 | NPI | - | NPPES |
| 758599 | Other | TX | BOYD FH PPO |
| 81342S | Other | TX | BOYD BLUE PPO |
| 742690907 | Other | TX | BOYD ST. D PPO |
| 81342S | Other | TN | BOYD BLUE HMO |
| 080173484 | Other | TX | BOYD RRB MEDICARE UNIT |
| 5670504 | Other | TX | BOYD AETNA HMO |
| 6632586003 | Other | TX | BOYD CIGNA PPO |
| 6632586002 | Other | TX | BOYD CIGNA HMO |
| 108993100 | Other | TX | BOYD PHCS PPO |
| 5670504 | Other | TX | BOYD AETNA PPO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | J0445 (Texas) | Primary |
| 207Q00000X | Family Medicine | 4301052929 (Michigan) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Family Medicine Associates Of Round Rock, P.a. | 6608851944 | 5 |
News Archive
More than three quarters of COVID-19 patients have at least one ongoing symptom six months after initially becoming unwell, according to research published in The Lancet.
Even without losing fat, more muscle appears to go a long way in fighting off the bad cardiovascular effects of obesity. That emerging evidence has scientists looking hard for new targets to uncouple the unhealthy relationship between fat and cardiovascular disease.
Merck, known as MSD outside the United States and Canada, today announced the European Medicines Agency (EMA) has accepted for review a Marketing Authorization Application (MAA) for pembrolizumab (MK-3475), the company's investigational anti-PD-1 antibody, for the treatment of advanced melanoma.
Using a basic genetic difference between men and women, the Translational Genomics Research Institute has uncovered a way to track down the source of a neurological disorder in a young girl.
› Verified 7 days ago
| Entity Name | Family Medicine Associates Of Round Rock, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730181793 PECOS PAC ID: 6608851944 Enrollment ID: O20040622000122 |
News Archive
More than three quarters of COVID-19 patients have at least one ongoing symptom six months after initially becoming unwell, according to research published in The Lancet.
Even without losing fat, more muscle appears to go a long way in fighting off the bad cardiovascular effects of obesity. That emerging evidence has scientists looking hard for new targets to uncouple the unhealthy relationship between fat and cardiovascular disease.
Merck, known as MSD outside the United States and Canada, today announced the European Medicines Agency (EMA) has accepted for review a Marketing Authorization Application (MAA) for pembrolizumab (MK-3475), the company's investigational anti-PD-1 antibody, for the treatment of advanced melanoma.
Using a basic genetic difference between men and women, the Translational Genomics Research Institute has uncovered a way to track down the source of a neurological disorder in a young girl.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James A Boyd Jr, MD 7200 Wyoming Spgs, Ste 600, Round Rock, TX 78681-4305 Ph: (512) 244-1995 | Dr James A Boyd Jr, MD 7200 Wyoming Spgs, Ste 600, Round Rock, TX 78681-4305 Ph: (512) 244-1995 |
News Archive
More than three quarters of COVID-19 patients have at least one ongoing symptom six months after initially becoming unwell, according to research published in The Lancet.
Even without losing fat, more muscle appears to go a long way in fighting off the bad cardiovascular effects of obesity. That emerging evidence has scientists looking hard for new targets to uncouple the unhealthy relationship between fat and cardiovascular disease.
Merck, known as MSD outside the United States and Canada, today announced the European Medicines Agency (EMA) has accepted for review a Marketing Authorization Application (MAA) for pembrolizumab (MK-3475), the company's investigational anti-PD-1 antibody, for the treatment of advanced melanoma.
Using a basic genetic difference between men and women, the Translational Genomics Research Institute has uncovered a way to track down the source of a neurological disorder in a young girl.
› Verified 7 days ago
Larissa Kaye Oneill, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7200 Wyoming Spgs # 15000, Round Rock, TX 78681 Phone: 512-218-8696 Fax: 512-218-9532 | |
David Alan Diaz, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15930 S Great Oaks Dr, A-200, Round Rock, TX 78681 Phone: 512-246-3338 Fax: 512-246-3368 | |
Dr. Aarti Prasad, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1001 S Mays St Ste 205, Round Rock, TX 78664 Phone: 254-577-9799 | |
Heather Celest Hammonds, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 302 University Blvd, Round Rock, TX 78665 Phone: 512-509-0200 | |
Sandeep Badyal, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1025 Sendero Springs Dr Ste 120, Round Rock, TX 78681 Phone: 737-220-7500 | |
Dr. Dana Ray Baker, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Chisholm Trail Rd Ste 450, Round Rock, TX 78681 Phone: 512-496-0394 Fax: 512-249-1719 | |
Dr. Anisha Virani, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 940 Hesters Crossing Rd, Round Rock, TX 78681 Phone: 512-244-9024 Fax: 512-406-7342 |